Product Pipeline

Pipeline

 
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >

Pipeline

 
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
 
Disc
Pre
P1
P2
P3
ONT-380 - HER2+ Breast Cancer
 
 
 
 
 
ONT-380 + C + T versus
Placebo + C + T
 
 
 
 
 
+ Capecitabine (C) /
+ Trastuzumab (T) / or
+ C & T
 
 
 
 
 
ONT380 + T-DM1
 
 
 
 
 
Research Programs
 
 
 
 
 
Cell Cycle Checkpoint
 
 
 
 
 
Immune Checkpoint
 
 
 
 
 
Licensed from Array BioPharma
Licensed from Sentinel Oncology
Research Collaboration with Adimab LLC
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >